High caffeine levels associated with weight loss and type 2 diabetes risk: BMJ

Published Date: 17 Mar 2023

UK: A recent study published in BMJ Medicine found that more caffeine in the blood can reduce the risk of type 2 diabetes and obesity. more...

Read Full News

Latest News

Boehringer-Zealand Drug Leads to 16.6% Weight Loss in Late-stage Trial

Boehringer Ingelheim said on Tuesday its experimental obesity drug led to average weight loss of up to 16.6% in ⁠a late-stage trial, as the unlisted German drugmaker seeks...

Mobile App for Hand Osteoarthritis Improves Pain, Function

Though currently available only in Norwegian, the researchers are expanding the app to more languages, including English.

Low Obesity-Related QOL Motivates Kids Weight Management

Families may be more motivated to participate in a pediatric weight management program when children and adolescents experience lower obesity-related quality of life.

Women With Acromegaly Face Greater Disease Burden Than Men

Women with acromegaly experience a significantly higher disease burden and poorer physical and mental quality of life than men.

OA, Knee Replacement Risk Highest With Sarcopenic Obesity

The findings suggest that resistance training is an important adjunct to other exercise for patients with knee osteoarthritis.

Can AI Ease Clinician-Patient Conversations About Obesity?

The Obesity Medicine Association’s interactive tool was designed to help clinicians practice real-world obesity-care discussions ‘grounded in science and compassion.’

Todays Updates

AstraZeneca to Invest $405 Million in Britain After US-UK Pharma Deal

Prime Minister Keir Starmer said on Wednesday that Britain's biggest company AstraZeneca would invest 300 million pounds ($405 ⁠million) in the country, after pausing...

Upadacitinib After TNF Inhibitor Failure Improves RA Control

In patients with active RA, switching to upadacitinib after failure of a single TNF inhibitor is more effective in reducing disease activity at 12 weeks than using a second TNF inhibitor adalimumab.

AAN 2026: Key RRMS Clinical Trial Updates

Dr Chu-Yueh Guo discusses promising MS trial results, including a study of fenebrutinib and positive safety data for ocrelizumab in pregnancy and pediatric patients.

Are Smartwatches Changing Arrhythmia Care?

Wearables can flag AF and capture symptoms in real time — but who truly benefits? Cardiologist Walid Amara, MD, outlines where smartwatches fit in clinical practice.

Why the FDA Rejected RP-1 in Melanoma: A Data Deep Dive

Dr Bishal Gyawali unpacks the FDA’s decision to deny RP-1 in melanoma, exploring why single-arm data and confounded response rates failed to meet the bar for clinical evidence.

Differential Diagnosis of Suspected Pulmonary Fibrosis and Efficacy of Approved Therapies

Experts review the differential diagnosis of suspected IPF, highlighting how a multidisciplinary approach confirmed the diagnosis and informed selection of optimal antifibrotic therapy.

‘Living’ Database Tracks Psilocybin Trials for Depression

Sypres.io continuously tracks and evaluates psychedelic research, offering an up-to date view of study findings, design, and limitations.

Todays Updates

AstraZeneca to Invest $405 Million in Britain After US-UK Pharma Deal

Prime Minister Keir Starmer said on Wednesday that Britain's biggest company AstraZeneca would invest 300 million pounds ($405 ⁠million) in the country, after pausing...

Upadacitinib After TNF Inhibitor Failure Improves RA Control

In patients with active RA, switching to upadacitinib after failure of a single TNF inhibitor is more effective in reducing disease activity at 12 weeks than using a second TNF inhibitor adalimumab.

AAN 2026: Key RRMS Clinical Trial Updates

Dr Chu-Yueh Guo discusses promising MS trial results, including a study of fenebrutinib and positive safety data for ocrelizumab in pregnancy and pediatric patients.

Are Smartwatches Changing Arrhythmia Care?

Wearables can flag AF and capture symptoms in real time — but who truly benefits? Cardiologist Walid Amara, MD, outlines where smartwatches fit in clinical practice.

Why the FDA Rejected RP-1 in Melanoma: A Data Deep Dive

Dr Bishal Gyawali unpacks the FDA’s decision to deny RP-1 in melanoma, exploring why single-arm data and confounded response rates failed to meet the bar for clinical evidence.

Differential Diagnosis of Suspected Pulmonary Fibrosis and Efficacy of Approved Therapies

Experts review the differential diagnosis of suspected IPF, highlighting how a multidisciplinary approach confirmed the diagnosis and informed selection of optimal antifibrotic therapy.

‘Living’ Database Tracks Psilocybin Trials for Depression

Sypres.io continuously tracks and evaluates psychedelic research, offering an up-to date view of study findings, design, and limitations.

Latest News

Boehringer Ingelheim said on Tuesday its experimental obesity drug led to average weight loss of up to 16.6% in ⁠a late-stage trial, as the unlisted German drugmaker seeks...

Though currently available only in Norwegian, the researchers are expanding the app to more languages, including English.

Families may be more motivated to participate in a pediatric weight management program when children and adolescents experience lower obesity-related quality of life.

Women with acromegaly experience a significantly higher disease burden and poorer physical and mental quality of life than men.

The findings suggest that resistance training is an important adjunct to other exercise for patients with knee osteoarthritis.

The Obesity Medicine Association’s interactive tool was designed to help clinicians practice real-world obesity-care discussions ‘grounded in science and compassion.’

News All Time

Continued Insulin Pump Use in the Hospital Improves Outcomes

Allowing patients to keep using their personal diabetes technology during hospitalization improves glycemic control and reduces length of stay.

Use of GLP-1s in Type 1 Diabetes Not Linked to Increased DKA

In single-center study, GLP-1 use in people with type 1 diabetes was associated with lower hospitalization rates.

UnitedHealth Flags Challenges in Medicare Obesity Drug Pilot

UnitedHealth said on Tuesday there are "challenges" around the Medicare pilot program to cover obesity drugs, ⁠adding uncertainty over whether health insurers would sign up...

More Teens Try to Lose Weight — Few See Real Results

Weight-loss attempts increase over two decades among US adolescents, but clinically meaningful weight loss remains uncommon despite widespread efforts.

Delay in Medicare Pilot for Obesity Drugs May Not Hurt Near-term Demand, Analysts Say

A delay in a Medicare pilot to cover obesity drugs due to health insurers' hesitation to participate in the program is unlikely to ⁠dent near-term demand for weight-loss...

Childhood ‘Adiposity Rebound’ Challenged as BMI ‘Fallacy’

A widely accepted marker of early obesity risk may instead reflect normal muscle development, with implications for how clinicians assess adiposity in children.

Hims & Hers Says It Has Steady Estrogen Patch Supply Amid US Shortages

Use ‌of estrogen patches rose after the FDA removed a longstanding safety warning and promoted hormone replacement therapy for some patients.

Sleep Apnea in Women Often Missed After Menopause

Sleep apnea in women may increase after menopause, yet atypical symptoms and low clinical suspicion delay diagnosis in routine practice.

Tzield Approved for Younger Children With Early-Stage T1D

The FDA expanded the drug’s indication from 8 years and older to 1 year and older for delaying progression of type 1 diabetes.

EU Review of New Weight-Loss Pill Concludes by Summer

The head of ⁠the European Medicines Agency said the ‌EU regulatory review of the first of a new generation of ‌weight-loss pills would be be concluded ‌this summer.

Novo Nordisk's Diabetes Pill Cuts Blood Sugar in Key Trial in Children

Novo Nordisk's oral GLP-1 drug significantly lowered blood sugar levels in children and adolescents with type 2 diabetes, ⁠meeting the main goal of a late‑stage trial, the...

Denosumab Not Tied to Atypical Fractures in Real-World Study

No increase in subtrochanteric or diaphyseal femur fractures was seen with denosumab use compared with bisphosphonates in 4 years of follow-up.

Lonapegsomatropin Shows Long-Term Benefit in Adult GHD

A 52-week extension study showed that the drug continues to maintain favorable body composition with no safety issues.

GLP-1 Boom Nudges Cannabis Dispensaries to Rethink Offerings

The surging popularity of GLP-1 weight-loss drugs is quietly reshaping the $40 billion U.S. cannabis market, experts and industry executives said, as retailers ⁠adjust...

Evidence Grows for Weight Loss Reducing Cancer Risk

With studies showing that the increased cancer risk linked to obesity can be reduced with weight loss, experts call for greater awareness.

Air Pollution’s Toll on Bone Health

Research links air pollution and heavy metals to accelerated bone loss and higher fracture rates, driven by systemic inflammation, oxidative stress, and endocrine disruption.

Recommended News For You

Delay of more than 42 days for breast cancer surgery raises death risk for certain subtypes, study finds

automated, precise reporting for clonality testing using NGS.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

MRI can save rectal cancer patients from surgery, study suggests

Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?

Since 2000, the outlook for multiple myeloma has improved.

The September 2018 issue of Medical Bulletin.

Recommended Articles For You

Beyond the Surface: Understanding the Silent Menace of Abdominal Hematomas 

Integrative Cancer Care: Nutrition, Social Work, Care Coordination, and Genetic Counseling 

AI in the War on Cancer: How Digital Tools are Revolutionizing Oncology 

Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

examining differences in the rates of breast reconstruction following mastectomies.

2.

Microplastics can cause malignant changes in lung cells

3.

The Effect of Common Steroids on Cancer Treatments.

4.

FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma

5.

Could semaglutide be used to treat addiction in addition to obesity?

1.

Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review

2.

Expanding Oncology Frontiers: Rare Cancers, Breakthroughs, and Precision Medicine Advances

3.

Understanding Purpura Fulminans: Causes, Symptoms and Treatment Options

4.

The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers

5.

What is Hemorrhagic Cystitis and How to Manage its Symptoms

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option

2.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

3.

Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.

4.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot